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SDS-PAGEases (RTKs) are activated by a ligand-mediated dimerization in the plasma
membrane and subjected to clusterization at a high local density of receptors and their membrane-anchored
ligands. Interactions between transmembrane domains (TMDs) were recognized to assist to the ligand-
binding extracellular domains in the dimerization of some RTKs, whereas a functional role of Eph-receptor
TMDs remains unknown. We have studied a propensity of EphA1-receptor TMDs (TMA1) to self-association
in membrane-mimetic environment. Dimerization of TMA1 in SDS environment was revealed by SDS-PAGE
and conﬁrmed by FRET analysis of the ﬂuorescently labeled peptide (Kd=7.2±0.4 μM at 1.5 mM SDS). TMA1
dimerization was also found in 1,2-dimyristoyl-sn-glycero-3-phosphocholine liposomes (ΔG=−15.4±0.5 kJ/
mol). Stability of TMA1 dimers is comparable to the reported earlier stability of TMD dimers of ﬁbroblast
growth factor receptor 3 and tenfold weaker than the stability of TMD dimers of glycophorin A possessing
high propensity to dimerization. Our results suggest that EphA1-receptor TMD contribute to the
dimerization-mediated receptor activation. An assumed role of the TMD interactions is the efﬁcient signal
transduction due to TMD-driving mutual orientation of kinase domains in dimers, while a relatively low force
of the TMD interactions does not prevent a ligand-controlled regulation of the receptor dimerization.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionSignaling pathways that are controlled by receptor tyrosine kinases
(RTKs) affect many fundamental cellular processes including the cell
cycle, cell migration, cell metabolism and survival, as well as cell
proliferation and differentiation [1]. Ephrin receptors (Ephs) uniting
eight type-A Ephs and six type-B Ephs are a family of RTKs, which is
involved together with their membrane-anchored ligands, ephrins, in
regulation of neural development and plasticity, cell proliferation and
morphogenesis, tissue patterning and angiogenesis [2].
Typically for RTKs, an extracellular ligand-binding and cytoplasmic
tyrosine kinase domains of Ephs are connected by a single transmem-
brane helix, and protein tyrosine kinase activity is controlled by
ligand-induced dimerization. In contrast to other RTKs, at high local
density, Eph dimers can progressively aggregate into larger clusters
[3,4], recruiting even monomeric Ephs in oligomerization and
activating them [5]. Such oligomerization is believed to be a way to
enhance considerably the signal transduction and change cellular
responses to Eph signaling [2,4].
Several sites that are responsible for receptor dimerization and
further low-afﬁnity clusterization have been found in the extracellular
and cytoplasmic domains of Ephs. Beside the high-afﬁnity ligand-7 495 336 17 66.
l rights reserved.binding interface, a globular extracellular domain of EphB2 and EphA3
receptors contain a second lower afﬁnity site, which is involved in the
dimerization of two Eph–ephrin complexes [6,7]. For EphA3, another
Eph/ephrin interaction interface was recognized in the cysteine-rich
extracellular region, which is near the ephrin-binding domain [7].
Sites that affect the low-afﬁnity receptor clusterization have been
found in the extracellular and cytoplasmic domains of Ephs [8,9].
Till now transmembrane domains (TMDs) of Ephs were considered
to play a passive role in ligand-induced Eph dimerization and
activation. At the same time TMDs were shown to be important for
the dimerization of at least some RTKs, including the ErbB (or HER)
family of epidermal growth factor RTKs [10] and ﬁbroblast growth
factor receptor 3 (FGFR3) [11]. In order to realize whether EphA1-
receptor TMD (TMA1) is involved in the receptor dimerization and (or)
clusterization, we assessed the oligomerization propensity of synthe-
sized TMA1 in themodel membrane-mimetic systems, using a sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and a
Förster resonance energy transfer (FRET) technique.
SDS-PAGE is often used to probe qualitatively occurrence of
transmembrane helix oligomerization [11–16]. TMDs from glyco-
phorin A and the inﬂuenza A virus M2 ion channel were shown to
migrate on SDS-PAGE gels according to their respective native-like
oligomeric states [15]. It should be mentioned that in some cases the
results of SDS-PAGE and other methods are in discordance. Thus TMDs
of the epidermal growth factor receptors ErbB1 and ErbB2migrated on
SDS-PAGE gels as monomers [15,16], whereas an evident dimerization
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TOXCAT, for analyzing TM domain interactions in Escherichia coli cell
membranes [10]. Just 5–10% of FGFR3-receptor TMDswere observed as
dimerswith SDS-PAGE even at a high amount of the peptide (15–22 μg)
loaded onto the gel, whereas a FRET technique detected distinctly
dimerization of these TMDs in liposomes [11]. Evidently, to generate a
robust conclusion, the study of TMD interactions requires comple-
mentary approaches that provide consistent results.
FRET is a recognized biophysical method for detecting intermole-
cular interactions in membrane-like systems [17–20]. It is based on a
nonradiative transfer of energy from an excited state of a donor
ﬂuorophore to an appropriate acceptor ﬂuorophore, which occurs
when the donor- and acceptor-bearing molecules approach closely
(b5 nm) each other. FRET was successfully used to clarify the basic
principles underlying structural organization of TMDs of membrane
proteins and their helix–helix interactions [11,21,22].
In the present work we have demonstrated that micelle-inserted
TMA1 migrated on SDS-PAGE gels as dimers. Using ﬂuorescently
labeled TMA1 and FRET technique we have conﬁrmed formation of
the TMA1 dimers in SDS micelles and found that dimerization of
TMA1 occurred in 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC) liposomes also. A TMA1 dimer dissociation constant and
free energy of dimerizationwere estimated. The results obtained by us
suggest a role for TMDs in the dimerization-mediated activation of the
EphA1 receptor.
2. Materials and methods
2.1. Peptide synthesis
The peptide TGGEIVAVIFGLLLGAALLLGILVFRSRR that corre-
sponded to TMD of human EphA1 receptor (residues 544–572; bold-
membrane part of the peptide; abbreviated as TMA1) was synthesized
in a stepwise manner by a solid-phase method using Fmoc/t-butyl
chemistry and trityl chloride resin (Pepchem, Tuebingen, Germany).
TMA1 was cleaved from the resin by the triﬂuoroacetic acid and
puriﬁed by reverse-phase HPLC with a C4 column (Vydac, 8×250 mm,
30 nm pore size, 5 μm particle size) using a linear water/acetonitrile
gradient (solvent A: 40% acetonitrile, 0.1% triﬂuoroacetic acid; solvent
B: 100% acetonitrile, 0.1% triﬂuoroacetic acid).
TMA1 labeled at N-terminus were obtained by treatment of the
peptidyl-polymer having a free N-α-amino group with 4-chloro-7-
nitrobenzofurazan (NBD, Acros Organics, Belgium) or sulforhoda-
mine B sulfonyl chloride (Rh, Acros Organic, Belgium) in dry
dimethylformamide for 6 h under the argon in the dark with N-
ethyldiisopropylamine as a base. The labeled peptides (abbreviated
below as NBD-TMA1 and Rh-TMA1) were cleaved from the resin
using a mixture of triﬂuoroacetic acid, H2O and 1,2-ethanedithiol
(95:2.5:2.5 v/v) for Rh-TMA1 or triﬂuoroacetic acid, H2O and
triisopropylsilane (95:2.5:2.5 v/v) for NBD-TMA1.
Product composition was conﬁrmed with matrix assisted laser
desorption ionization mass spectrometry (MALDI-MS). Purity (N95%)
of TMA1, NBD-TMA1 and Rh-TMA1 was assessed with analytical
reverse-phase HPLC. It should be mentioned that TMA1 and labeled
TMA1 had well resolved peaks in chromatograms that facilitated
puriﬁcation of the labeled peptides.
2.2. SDS-PAGE
SDS-PAGE was performed as was described elsewhere [23].
Different amounts of TMA1 were dissolved in 20 mM SDS, and
mixed with equal volumes of a SDS-PAGE loading buffer, incubated at
95 °C for 5 min and loaded on the 16.5% polyacrylamide tris–tricine
gel. A set of ultra low molecular mass markers (Sigma, St. Lois, MO,
USA) was used as a reference. The peptides were visualized with
Coomassie blue.The cross-linked TMA1 dimers were obtained as follows: freshly
prepared 1.65 mM glutaraldehyde (Acros Organics, Belgium) was
added to 330 μM TMA1 in 20 mM SDS, 5 mM sodium phosphate (pH
7.0) to a ﬁnal concentration of 165 μM. The sample was incubated for
45 min at 25 °C. The reaction was stopped with SDS-PAGE loading
buffer, and the sample was analyzed with SDS-PAGE as described
above.
2.3. Preparation of TMA1-contained micelles and liposomes
Peptides were dissolved in TFE (Merck, Germany). TMA1 con-
centration was measured with UV absorption spectroscopy using the
extinction coefﬁcient of 390 M−1 cm−1 at 257.5 nm calculated from
the contribution of two phenylalanine residues per TMA1 molecule.
The concentrations of NBD-TMA1 and Rh-TMA1 were determined
with absorption spectroscopy using known extinction coefﬁcients of
chromophores (13000 M−1 cm−1 at 450 nm for NBD, 84000 M−1 cm−1
at 560 nm for Rh). Prepared in this way equimolar solutions of TMA1
and labeled TMA1 in TFE were found to have identical CD spectra
(Fig. 1, b). Accordingly, CD spectroscopy was often used to measure or
correct concentrations of the studied peptides. Much less sample
volume is required for recording CD spectrum as compared to
absorption spectrum.
To prepare SDSmicelles with peptides, the peptide solutions in TFE
were mixed with buffered SDS solution, lyophilized and dissolved
with phosphate buffered saline at a ﬁnal SDS concentration of 1.5 mM.
These stock solutions were diluted with buffered SDS (1.5 mM) to
required peptide concentrations.
TMA1-contained liposomes were obtained as follows: solutions of
the peptides and 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC, Avanti Polar Lipids, Pelham, AL, USA) in TFE were mixed to
achieve a required peptide/lipid molar ratio (varied from 1/50 to 1/
600). Samples were diluted with water (50% v/v), lyophilized and
dissolved with phosphate buffered saline (20 mM sodium phosphate,
150mMsodiumchloride, pH7.5) at aﬁnal lipid concentration of 50 μM.
The probeswere freeze–thawed several times and equilibrated at 30 °C
for 12 h before any measurements. The multilamellar liposomes
obtained in this way were used for ﬂuorescence experiments.
For CD measurements, liposomes were prepared as described
above at a DMPC concentration of 5 mM and a peptide/lipid molar
ratio of 1/100 and subjected to sonication in order to produce small
unilamellar vesicles. Sonication was performed to reduce light
scattering, which is a critical factor for CD measurements in the far
UV region.
2.4. CD spectroscopy
CD spectra were recorded with a J-810 spectropolarimeter
(Jasco, Tokyo, Japan) in the 190–250 nm region (0.2 nm step,
20 nm/min, 1 nm slit width). The peptides in SDS micelles and TFE
were measured at 25 °C. The experiments with liposomes were
performed at 30 °C (DMPC phase transition temperature is 23 °C).
The 0.01 and 0.1 cm path-length quartz cells with a detachable
window (Hellma, Germany) were used. Baseline was measured for
TFE, SDS micelles or liposomes without the peptide and subtracted
from the corresponding peptide spectrum. Peptide secondary
structure was analyzed with CONTINLL and CDSSTR programs
[24,25].
Multilayered samples for oriented CD (OCD) measurements were
prepared as described elsewhere [26]. Brieﬂy, TMA1 and lipids were
co-dissolved in TFE/chloroform mixture (3:1 v/v) at the peptide/lipid
molar ratio of 1:50. Dropwise, the solution was deposited on a
detachable window of the quartz cell, and the solvent was evaporated
with an argon stream. A small drop of water was placed in the cell
during its mounting, and the sample was hydrated for 12 h at 30 °C.
The hydrated sample was present on the quartz window as a clear gel-
Fig. 1. CD spectra of TMA1 (a) and labeled TMA in TFE (b), SDS micelles (c) and DMPC liposomes (d).
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light normal to the multilayer lipid surface. A signal/noise ratio was
increased by averaging three consequent scans. Measurements were
repeated for each sample rotated around the light axis in increments
of 60°, and six recorded spectrawere averaged in order to eliminate an
inﬂuence of sample inhomogeneity on the OCD spectrum.
2.5. FRET measurements
FRET measurements were performed using a LS55 spectroﬂuori-
meter (Perkin Elmer, Waltham, MA). For NBD/Rh donor/acceptor pair,
an excitation wavelength was 430 nm, and emission spectra were
collected in the 450–700 nm region. Spectral widths of slits for
excitation and detection were 2.5 and 10 nm, respectively. Measure-
ments were done in a quartz cell (2×10 mm) at 30 °C for liposomes
and 25 °C for SDS micelles. Absorption of any sample at the excitation
wavelength was less than 0.1 optical units per cm in order to prevent
inner ﬁlter effect. Background spectra were measured from TMA1
containing liposomes (SDS micelles) and subtracted from the
ﬂuorescence emission spectra. In the FRET measurements, the
ﬂuorescence emission spectra were further subjected to linear
deconvolution into two components, namely, donor and acceptor
emission spectra.
An energy transfer (E) was calculated as:
E = ID−IDAð Þ=ID; ð1Þ
where ID and IDA are the integrated intensities of donor emission
spectra of samples containing only donor-labeled peptides and
samples with both donor- and acceptor-labeled peptides, respectively,
corrected for a contribution of light scattering and subjected to the
deconvolution procedure (in the case of IDA).
The experimental dependence of E on a peptide/lipid molar ratio C
was analyzed with an equation
E Cð Þ = Ed Cð Þ + Es Cð Þ; ð2Þ
where Ed(C) is a term describing a contribution of dimerization-related
FRET, and Es(C) is a term, which corresponds to a contribution ofspontaneous FRETarising due to spontaneous proximity of acceptor and
donor chromophores randomly distributed in the lipid bilayer [27].
Ed Cð Þ = 0:5 C= Kd + Cð Þ; ð3Þ
where factor 0.5 corresponds to 50% FRET efﬁciency that is a limit for
dimerization-related FRET probed with an equimolar donor–acceptor
mixture. Hereweassume that TMA1 formsdimers of a parallel (head-to-
head) structure. This assumption was recently conﬁrmed by a NMR
analysis of the TMA1 dimer structure in lipid bicelles (Bocharov E.,
Mayzel M. and Arseniev A., unpublished results). Kd is dissociation
constant of TMA1 dimers in the lipid bilayer deﬁned as
Kd = C2m=Cd; ð4Þ
where Cm and Cd are mole fraction concentrations of monomers and
dimers in the lipid bilayer (monomer/lipid anddimer/lipidmolar ratios),
respectively.
Es Cð Þ = 1− 0:65 exp −2:31 K2  Cð Þ− 0:35 exp −K2  Cð Þ; ð5Þ
where K2 is a parameter, that is deﬁned in the course of curve ﬁtting.
This function was chosen in accordance with a theoretical analysis of
the spontaneous FRET problem published earlier [27], assuming that
the distance of closest approach between donor and acceptor is equal
to 0.
Data of the FRET experiments in SDS micelles were analyzed with
Eq. (3), but C was a peptide concentration in SDS solution. Dissociation
constant of TMA1 dimers in SDS micelles, Kd, was deﬁned with Eq. (4),
where Cm and Cd are molar concentrations of monomers and dimers
in the solution.
3. Results
3.1. TMA1 interactions as probed with SDS-PAGE
SDS-PAGE revealed that mobility of micelle-inserted TMA1
(3025.7 Da) depended on peptide amount loaded to gels (Fig. 2).
TMA1 mobility approached to that of the 6.5 kDa marker (i.e. to
Fig. 3. An OCD spectrum of TMA1 in a DMPC ﬁlm (solid line) and a CD spectrum of TMA1
liposomes (dotted line).
Fig. 2. Oligomeric state of TMA1 as probed by SDS-PAGE. One, two, four and eight
micrograms of TMA1 (3025.7 Da) were loaded on 16.5% polyacrylamide tris–tricine gels
(lanes 2, 3, 4 and 5, respectively). Lane 7 shows TMA1 (5 μg) cross-linked with
glutaraldehyde in 20 mM SDS. Lanes 1 and 6 show molecular mass markers.
2364 E.O. Artemenko et al. / Biochimica et Biophysica Acta 1778 (2008) 2361–2367calculated mobility of TMA1 dimer) at high amount of the loaded
peptide (Fig. 2, lane 5). We did not observe two separate bands clearly
indicating monomer and dimer positions, but a smear of the TMA1
band was detected. The revealed pattern may reﬂect a dynamic
equilibrium between dimeric and monomeric states of TMA1 during
the electrophoresis. This equilibrium shifts to dimers at high amount of
the loaded peptide (Fig. 2, lane 5). In order to conﬁrm this assumption,
we have analyzed mobility of TMA1 cross-linked with glutaraldehyde.
Cross-linking could occur only through the N-terminal amino group of
TMA1 that predeﬁned dimer but not oligomer formation. As expected,
a narrow band of cross-linked dimers was observed closely to the
positions of the 6.5 kDa marker, and a wide band of unreacted peptide
was also present at intermediate position between the 3.5 and 6.5 kDa
marker bands (Fig. 2).
The results of SDS-PAGE analysis indicate that TMA1 is able to form
dimers in SDS environment, but this conclusion needs to be conﬁrmed
by independent experimental techniques.
To investigate further the TMA1 interactions by a FRET technique,
NBD-TMA1 and Rh-TMA1 were used. The selected ﬂuorophores (NBD
and Rh) are a well-known donor–acceptor pair with a Förster radii
(that is a distance where FRET efﬁciency is reduced twofold) of ~50 Å
[28]. SDS-PAGE revealed similar migration of TMA1 and labeled TMA1
(data not shown) thus demonstrating that attachment of ﬂuorophores
does not affect dimerization ability of the peptide.
3.2. Reconstruction of TMA1 in SDS micelles and DMPC liposomes
A special care is required to reconstruct completely highly
hydrophobic peptides in membrane-like systems and to equilibrate
their distribution in lipid vesicles [21]. In the case of TMA1 and labeled
TMA1, the reconstruction was followed with CD spectroscopy and
characterized by an increase in intensity of the spectrum, whichTable 1
Structure of TMA1 and labeled TMA1 as probed with CD spectroscopy
α-helix, % Random coil, % β-turns, % β-sheets, %
TMA1 in TFE 76±5 18±3 4±3 2±1
NBD-TMA1 in TFE 77±6 15±5 5±3 3±1
Rh-TMA1 in TFE 74±6 17±4 7±3 3±1
TMA1 in DMPC liposomes 81±2 12±2 4±1 3±1
NBD-TMA1 in DMPC liposomes 78±4 12±2 7±1 3±2
Rh-TMA1 in DMPC liposomes 74±4 15±3 8±1 3±1
TMA1 in SDS 79±6 16±4 3±1 2±1
NBD-TMA1 in SDS 77±5 14±5 6±1 3±1
Rh-TMA1 in SDS 74±4 16±4 7±1 3±1
Peptide structures were calculated using CONTINLL and CDSSTR programs [24,25], and
the results were averaged.corresponded to α-helical conformation. The spectrum of TMA1 in
TFE, the solvent, which promotes α-helix formation, was used as a
reference when we searched for the right conditions for a reconstruc-
tion of TMA1 and labeled TMA1 in SDS micelles and DMPC liposomes.
Twelve hour incubation of the peptides in DMPC and 1 h incubation in
SDS were concluded to be sufﬁcient to achieve the equilibrium. At the
end of this period the peptides were found to be predominantly
helical in both DMPC liposomes and SDS micelles (Fig. 1, Table 1).
Labeling of TMA1 with NBD or Rh did not disturb the peptide
structure in TFE (Fig. 1, b, Table 1). Moreover, TMA1 and labeled TMA1
adopted very similar conformation that was reproduced well in DMPC
liposomes and SDS micelles (Fig. 1, Table 1).
To clarify a TMA1 α-helix orientation relative to a DMPC bilayer
surface, the OCD measurements were performed for the peptide in a
hydrated DMPC ﬁlm. The OCD spectrum of TMA1 is different from the
CD spectrum of the peptide in liposomes (Fig. 3), that is an indicator of
ordered mutual orientation of helices. Helices, which are orthogonal
to the bilayer surface and parallel to that, have characteristicallyFig. 4. FRET analysis of TMA1 interactions in SDS micelles. (a) Dependence of the energy
transfer from the TMA1 concentration as measured with equimolar NBD-TMA1/
Rh-TMA1 mixture in SDS micelles. Solid line-best ﬁt of the data with a function
described by Eq. (3). (b) Energy transfer as a function of donor/acceptor ratio at the
constant total peptide (5 μM) and detergent (1.5 mM) concentrations. Solid line-best ﬁt
of the data with a linear function.
Fig. 5. FRET analysis of TMA1 interactions in DMPC liposomes. (a) Dependence of the
energy transfer from the peptide/lipid molar ratio as measured with equimolar NBD-
TMA1/Rh-TMA1 mixture. A DMPC concentration is 50 μM. Solid line-best ﬁt of the data
with a function described by Eq. (2). (b) Energy transfer as a function of donor/acceptor
ratio at the constant total peptide and lipid concentrations. A total peptide/lipid molar
ratio is 0.003. Solid line-best ﬁt of the data with a linear function.
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maximum at 200 nm and a single minimum at 230 nm without an
additional minimum at 205 nm (Fig. 3). These spectral features are
characteristic for the transmembrane orientation of a peptide [29–31].
Thus, the CD data conﬁrmed incorporation of the labeled peptides
in SDS micelles and DMPC liposomes and as well as the formation of
α-helices oriented normally to the DMPC bilayer surface. These results
were considered by us as a solid background to perform the study of
TMA1 interactions in SDS micelles and liposomes with a FRET
technique.
To provide (improve) reproducibility of FRET measurements, an
equilibrium of peptide distribution in liposomes (micelles) was
controlled by measuring the energy transfer in samples as a function
of time. Temporal stability of the energy transfer at a ﬁxed labeled
peptide/lipid molar ratio was considered as an additional evidence of
the uniform peptide distribution and equilibrium of the self-
association.
3.3. TMA1 dimerization in SDS micelles
Self-association of the peptides was probed at a ﬁxed SDS
concentration and 1:1 NBD-TMA1/Rh-TMA1 molar ratio, whereas a
total peptide concentration varied. Micelles with NBD-TMA1 served as
a “no FRET control”. FRET measurements revealed an increase in an
energy transfer (E) as a function of the peptide concentration in
micelles (Fig. 4, a) that is consistent with the concentration-
dependent self-association of peptides. An addition of non-labeled
TMA1 to the micelles containing a ﬁxed concentration of the labeled
peptides diminished FRET (data not shown). Non-labeled TMA1 can
affect oligomerization-induced FRET by substituting NBD-TMA1 or
Rh-TMA1 in self-associates, but it cannot change the effect if FRET
arises due to spontaneous proximity of donor to acceptor. Therefore, a
speciﬁc self-association of peptides is a reason of the registered FRET
effect (Fig. 4, a).
As shown earlier [32], if the interacting molecules form dimers but
not higher order aggregates, the energy transfer (E) depends linearly
on the donor/acceptor molar ratio. Moreover, the linear dependence
indicates that the equilibrium constants of donor–donor, acceptor–
acceptor, and donor–acceptor dimerization are the same [32]. We did
observe such a linear dependence in the experiment where SDS and
total peptide concentrations were ﬁxed while a NBD-TMA1/Rh-TMA1
molar ratio varied (Fig. 4, b).
The experimental data (Fig. 4, a) were ﬁtted with Eq. (3), and Kd
was estimated to be 7.2±0.4 μM at the 1.5 mM SDS concentration. It is
known that observed Kd depends on the detergent concentration [21].
That is why the direct interpretation of Kd as a measure of ΔG is not
possible without special complicated analysis [21]. In fact, the results
of FRET and SDS-PAGE analysis are in agreement concerning the TMA1
ability to form dimers in SDS environment.
3.4. TMA1 dimerization in liposomes
To probe a self-association of the peptides in liposomes, a
DMPC concentration was ﬁxed, while a peptide concentration
varied at the constant (1:1) NBD-TMA1/Rh-TMA1 molar ratio.
Concentration-dependent FRET was distinctly observed in these
experiments (Fig. 5, a).
To clarify whether TMA1 forms dimers or higher order aggregates
in liposomes, FRET was measured at a ﬁxed DMPC concentration and
total peptide/lipid molar ratio, whereas a NBD-TMA1/Rh-TMA1 molar
ratio varied. A linear dependence of the energy transfer (E) on the
donor/acceptor molar ratio was observed (Fig. 5, b). As discussed
above, this result indicates that dimers of TMA1 but not higher order
aggregates are formed in DMPC liposomes.
When a concentration of labeled peptides is sufﬁciently high,
FRET can arise because of spontaneous proximity of acceptor anddonor chromophores that are randomly distributed in the lipid
bilayer. This effect can contribute to the measured FRET efﬁciency
together with speciﬁc dimerization-related FRET. In our experi-
ments, the observed FRET efﬁciency approaches to 0.8 (Fig. 5, a),
whereas a dimerization-related FRET efﬁciency cannot exceed 0.5,
when it is probed with an equimolar donor–acceptor mixture.
Accordingly, the experimental data (Fig. 5, a) were analyzed with
Eq. (2) as a sum of two terms, describing dimerization-related and
spontaneous FRET. A mole fraction dissociation constant Kd of TMA1
in the lipid bilayer was estimated to be (2.2±0.4)×10−3. It should be
mentioned that a peptide concentration in solution has no sense,
the lipids are a “solvent” for a hydrophobic peptide, and the peptide
mole fraction (peptide/lipid molar ratio) deﬁnes the association
process [33].
The free energy of dimerization ΔG is given by
ΔG = −RT ln 1=Kdð Þ: ð6Þ
Accordingly, the free energy of dimerization for TMA1 in DMPC
liposomes is equal to −15.4±0.5 kJ/mol.
4. Discussion
Our results demonstrate that TMDs of human EphA1 receptor
form dimers in membrane-mimetic environment even in the
absence of extracellular and cytoplasmic domains of the receptor.
TMA1 self-association was observed in a lipid bilayer and in
detergent micelles. In other words, it occurs in different mem-
brane-mimetic systems, and one may expect that dimerization
ability of TMD of EphA1 is preserved in a cellular membrane. If so, a
role of EphA1-receptor TMD is not restricted to membrane
anchoring.
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Kd of TMD of glycophorin A, the protein, which forms stable dimers in
erythrocyte membrane, was reported to be 0.68 μM in 1.4 mM SDS
micelles [21], that is approximately tenfold lower than that of TMA1
at a similar SDS concentration. Dimerization ability of TMA1 corres-
ponds well to that of FGFR3-receptor TMD. The mole fraction dis-
sociation constant of FGFR3-receptor TMD in the lipid bilayer was
reported to be 5.7×10−3 [11]. The free energy of dimerization was
calculated as −13±2 kJ/mol [11] and −15.4±0.5 kJ/mol for FGFR3-
receptor TMD and TMA1, respectively.
EphA1-receptor TMD contains G-x-x-x-Gmotif (x is any aminoacid
residue), which is supposed to be a framework for transmembrane
helix–helix association [34,13] when a surrounding sequence does not
disrupt such an association [35]. It contains two consecutive ﬁve-
residue segments (GLLLG and ALLLG) corresponding to a general motif
X1-x-x-X2-X3 (where X1=Gly, Ala, Ser, Thr, or Pro; X2=Ala, Val, Leu, or
Ile; X3=Gly or Ala), which is assumed to assist in dimerization of
transmembrane helices in the family of growth factor receptors [36].
One or both of these segments can form the dimerization interface in
TMA1.
Currently, the particular role of assumed TMD dimerization in the
EphA1 signal transduction still needs to be clariﬁed. TMDs of EphA1
form dimers but not higher order aggregates in our experiments. Thus
we suppose that TMD interactions are involved in regulation of the
receptor dimerization but not in the EphA1 clusterization. The
interactions between TMDs may serve to enhance ligand-induced
dimerization of EphA1 and assist in mutual orientation of receptor
molecules in dimers required for receptor phosphorylation or/and be a
driving force for a basal level of ligand-independent receptor dimeriza-
tion and activation. A limited population of active dimers is supposed to
exist even in the absence of ligand binding [1]. The extracellular domain
of EGFR (ErbB1) conjugated with TMD has a higher level of ligand-
induced dimerization as compared with the extracellular domain itself
[37] exemplifying the situation, when TMD of RTK enhances ligand-
induced dimerization of the receptors. Insulin andNeu (ErbB2) RTKs lost
activity when their TMDs were substituted with TMD of glycophorin A
[38,39]. In those cases strong dimerization promoted by TMD of
glycophorin A seems to lock the modiﬁed receptor dimer in a
conformation being inappropriate for RTK activation [39,40]. In favor
of this assumption the rotational coupling of the transmembrane and
kinase domains of Neu RTK was reported [41]. Therefore, TMD
association may play an additional functional role providing a right
mutual orientation of dimer subunits at least in some RTKs.
In conclusion, our results concerning moderate dimerization
ability of EphA1-receptor TMD, as a representative of ephrin RTKs,
supports the hypothesis that relatively low dimerization propensity
of TMDs may be expected for all RTKs [11]. An assumed role of
TMD interactions is the efﬁcient signal transduction due to TMD-
driving mutual orientation of kinase domains in dimers, while a
relatively low force of TMD interactions does not prevent a ligand-
controlled regulation of the monomer/dimer equilibrium of
receptors.
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